The Globe and Mail3d
Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership
Nov. 06, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments ... Refer to Note 17 - Discontinued Operations within the Company's most recent Form 10-Q for additional information. 2 Insurance Benefits ...
The Globe and Mail3d
Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
The pivotal CLOVER-WaM (NCT02952508) trial assessed the efficacy and ... including our Form 10-K/A for the year ended December 31, 2023, and our Form 10-Q for the quarter ended June 30, 2024. These ...